Clinical Trials Sponsored by Macera therapeutics

Total 6949 results

Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

Dyspepsia

Russian Federation
Pacira Pharmaceuticals, Inc

Terminated

Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine Surgeries (FUSION)

Postoperative Pain Management

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Acute Respiratory Viral Infections

Russian Federation, Kazakhstan
Pacira Pharmaceuticals, Inc

Completed

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Postoperative Pain | Posterolateral Thoracotomy

Bulgaria, United States, Czechia, Georgia, Poland
Acerta Pharma BV

Completed

A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

Healthy Participants

United States
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of ACP-196 on the Heart Rate-corrected QT Interval in Healthy Adult Participants

Healthy Volunteers

United States
Pacira Pharmaceuticals, Inc

Terminated

Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section

Pain

United States
Pacira Pharmaceuticals, Inc

Completed

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair (702)

Hernia

United States
Pacira Pharmaceuticals, Inc

Completed

EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty

Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Phase 2 Dose-Ranging Study of SKY0402 for Prolonged Postoperative Analgesia in Subject Undergoing Hemorrhoidectomy

Postoperative Pain

United States, Georgia
Pacira Pharmaceuticals, Inc

Completed

Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty

Postoperative Pain

United States
Pacira Pharmaceuticals, Inc

Completed

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

Postoperative Pain

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic Stroke

Ischemic Stroke | Mild Cognitive Impairment

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Impaired Glucose Tolerance

Russian Federation
Pacira Pharmaceuticals, Inc

Completed

Evaluation of the Safety, Efficacy, and Pharmacokinetics of SKY0402 in Subjects Undergoing Inguinal Hernia Repair

Inguinal Hernia
Materia Medica Holding

Completed

Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults

Acute Upper Respiratory Tract Infections

Russian Federation
Materia Medica Holding

Completed

Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders

Anxiety

Russian Federation, Kazakhstan
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

Viral Intestinal Infection

Russian Federation, Uzbekistan
Materia Medica Holding

Completed

Efficacy and Safety Clinical Trial of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain Injury

Sequelae of Perinatal Brain Injury

Russian Federation
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus

Type I Diabetes Mellitus

Russian Federation
Acerta Pharma BV

Withdrawn

A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma
Pacira Pharmaceuticals, Inc

Completed

Pain Control in Bariatric Patients: EXPAREL(R) vs. the On-Q(R) Pain Ball

Obesity

United States
Pacira Pharmaceuticals, Inc

Terminated

Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast Augmentation

Pain

United States
Ladera Medical
Avania

Not yet recruiting

The Ladera Large Bore Closure Feasibility Study

Vascular Closure | Femoral Arteriotomy Closure
Materia Medica Holding

Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Cystitis Chronic | Cystitis Bacterial | Recurrence of Chronic Bacterial Cystitis

Russian Federation
Pacira Pharmaceuticals, Inc

Recruiting

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Postoperative Pain

United States
Pacira Pharmaceuticals, Inc

Recruiting

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

Healthy

United States
Barcelona Macula Foundation

Recruiting

Structural and Functional Characterization of Rare Ocular Diseases (RADIS)

Retinitis Pigmentosa | Choroideremia | Stargardt Disease 1 | Best Disease | Pattern Dystrophy of Macula

Spain
Acerta Pharma BV

Active, not recruiting

Acalabrutinib in Combination With Anti-CD20 and Venetoclax in Relapsed/Refractory or Untreated CLL/SLL/PLL

Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Acerta Pharma BV

Active, not recruiting

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

United States
Acerta Pharma BV

Active, not recruiting

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Acerta Pharma BV

Active, not recruiting

Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma

Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)

United States, United Kingdom
Acerta Pharma BV

Active, not recruiting

A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL

Chronic Lymphocytic Leukemia

Austria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
Acerta Pharma BV

Active, not recruiting

Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL (ElevateTN)

Chronic Lymphocytic Leukemia

United States, Italy, Spain, Belgium, Brazil, Poland, United Kingdom, Canada, Germany, Australia, Israel, Hungary, France, New Zealand, Chile, Lithuania, Sweden, Colombia
Pacira Pharmaceuticals, Inc
Pacira Pharmaceuticals, Inc

Active, not recruiting

Study to Evaluate the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

Hong Kong, United States, Denmark, Estonia, Lithuania, Australia, Canada, Romania
Pacira Pharmaceuticals, Inc

Completed

Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects

Histological Response of Tissue to Cold

United States
Pacira Pharmaceuticals, Inc

Completed

Study Evaluating the Treatment of Occipital Neuralgia

Occipital Neuralgia

United States
Pacira Pharmaceuticals, Inc

Completed

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States, Canada
Pacira Pharmaceuticals, Inc

Completed

Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device

Upper Limb Spasticity

United States
Acerta Pharma BV

Active, not recruiting

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Waldenström Macroglobulinemia (WM)

Spain, United States, United Kingdom, France, Italy, Greece, Netherlands
Materia Medica Holding

Completed

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Post-acute COVID-19 Syndrome

Russian Federation
Pacira Pharmaceuticals, Inc

Completed

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of EXPAREL, EXPAREL Admixed With Bupivacaine HCl vs. Bupivacaine HCl Administered as Combined Sciatic and Saphenous Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries (STRIDE)

Bunion | Midfoot Fusion | Total Ankle Arthroplasty | Lower Extremity Surgery | Metatarsophalangeal Fushion | Hindfoot Fushion

United States
Pacira Pharmaceuticals, Inc

Completed

Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section (CHOICE)

Pain Management | Elective Cesarean Section

United States
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of Pharmacokinetics (PK) of Acalabrutinib and Its Active Metabolite (ACP-5862) When Administered Alone and With Moderate CYP3A4 Inhibitors Fluconazole or Isavuconazole in Healthy Adult Participants

Healthy Volunteers

United States
Materia Medica Holding

Completed

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

Cerebral Atherosclerosis

Russian Federation
Pacira Pharmaceuticals, Inc

Completed

Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

Healthy Volunteers

United States
Pacira Pharmaceuticals, Inc

Terminated

EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries (TRANSCEND)

Pain

United States
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

Healthy Volunteers

United States
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of [14C]Acp-196 (Acalabrutinib) in Healthy Adult Participants

Healthy Volunteers

United States

3

Subscribe